The prolyl hydroxylase inhibitor roxadustat: Paradigm in drug discovery and prospects for clinical application beyond anemia
Kaijun Su, Zhihong Li, Yan-Cheng Yu, Xiaojin Zhang
Topics & Concepts
ErythropoietinDrugMedicineClinical trialHypoxia-inducible factorsDrug discoveryAnemiaPharmacologyBioinformaticsInternal medicineBiologyBiochemistryGeneCancer, Hypoxia, and MetabolismEpigenetics and DNA MethylationAdrenal and Paraganglionic Tumors